LKBC
ABBV icon

L.K. Benson & Company’s AbbVie ABBV Stock Holding History

L.K. Benson & Company’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Hold
1,892
– – 0.14% 82
2026
Q1 		$411K Hold
1,892
– – 0.14% 85
2025
Q4 		$432K Buy
1,892
+65
+4% +$14.8K 0.22% 81
2025
Q3 		$423K Sell
1,827
-75
-4% -$15.3K 0.23% 77
2025
Q2 		$353K Sell
1,902
-50
-3% -$9.29K 0.22% 78
2025
Q1 		$409K Hold
1,952
– – 0.28% 72
2024
Q4 		$347K Buy
+1,952
New +$359K 0.24% 69

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

L.K. Benson & Company's ABBV Position: Q2 2026 in Review

L.K. Benson & Company held its AbbVie (ABBV) position steady in Q2 2026 at 1,892 shares worth $476K. The position accounts for 0.14% of the portfolio, ranked #82.

L.K. Benson & Company first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • L.K. Benson & Company held 1,892 shares of AbbVie worth $476K as of Q2 2026.
  • L.K. Benson & Company left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.14% of L.K. Benson & Company's portfolio in Q2 2026, its #82 holding.
  • L.K. Benson & Company first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on L.K. Benson & Company's 13F filing for Q2 2026, filed 24 Jul 2026.